ClinicalTrials.gg
Sign In
Status unknownNCT03272282labourRecordUpdated Sep 6, 2017

Paperless Parotograph in Evaluation of Labour

An observational study in Labor Complication, sponsored by Assiut University. Status unknown at 2 sites in Egypt. Open to female participants aged 20 Years to 42 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-09-06.

Sponsored by Assiut University · Observational

The sponsor has not verified this record recently (last verified Sep 2017), so the status shown — last known as Recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-crossover
Time perspective
Prospective
Enrollment
450
Ages
20 Years to 42 Years
Sex
Female
01

Study summary

Using Paperless partograph management of labour as simple tool to prevent obstructed labour or prolonged labour or its complications at the mother or her fetus

Read the detailed description

WHO PARTOGRAPH is very work load need more time and more stuff in both treaning and learning for plotting and for drowning but inside labour room needing simple partograph playing the simple partograph beast role in management of labour and stand test against time for saving live of labour women and her child Paperless parotograph can help obestitricianes to talk decision about when to transferr the labourus women to higher centers on to make medical intervention or what time to end labour by caesarian section

02

Conditions studied

  • Labor Complication

Keywords

  • WHO PARTOGRAPG.OBSTRUCTED LABOUR. managment of labour
03

In context

Obstetric Labor Complications

88 studies on the registry are indexed under Obstetric Labor Complications; 24 are open to participants now.

This study's planned enrollment of 450 is above the median of 300 across 25 observational studies indexed under Obstetric Labor Complications.

Browse Obstetric Labor Complications studies →

Lead sponsor

Assiut University is the lead sponsor of 5,079 studies on the registry; 2,177 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Browse Assiut University studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 42 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

By following women during labour using well structured questions developed by researcher and filling well designed Paperless partograph stumped THE collected data will be analysed using special computer program SPSS tactical program for social science

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • women ln active phase of labour
  • With single pregnanncy
  • living fetus
  • cephalic presentation
  • occipt anterior
  • 36 weak gestional age up to full term

Exclusion criteria

Exclusion Criteria:

  • preterm . .or women with antipartum hemorrhage .
  • or multipregnanncy
  • previous utrine surgery
  • or abnormal cardiotocograph(CTG )PATTERN
  • or any heart disease of mother or his fetus
05

Study design

Observational model
Case-crossover
Time perspective
Prospective
Enrollment
450 participants (estimated)
Patient registry
No
Biospecimen retention
Samples without dna
06

What researchers measure

Primary outcomes

  1. Progress of labour

    Cervical dilatation 1 cm / hour

    Time frame: up to 5 months

Secondary outcomes

  1. Charcteristics of new_born

    Apgar score at1minute and Apgar score at 5minutes

    Time frame: up to 1 month

  2. Time taken after ALERT EDT

    Primgravida and Multipara

    Time frame: up to 2 months

Other outcomes

  1. Mode of delivery

    Normal vaginal delivery or caesarean section

    Time frame: up to 9 weeks

07

Study locations

2 of 2 sites recruiting
  • Faculity of Medicine Assiut University
    Asyūţ, Assiut 71723, Egypt
    Recruiting
  • Faculity of Medicine
    Assiut, 71723, Egypt
    Recruiting
    • abobaker khalil abass metwally, professor · Contactkotbnetw@hotmail.com · 002010033568474
    • said mohamed mostafy, profossor · Contactsaidmostafy9@gmail.com · 00201007599819
    • ayman darder abed algwad mohamed, specialest · Principal investigator
08

References and documents

Publications

  • Fatehi F, Gray LC, Wootton R. How to improve your PubMed/MEDLINE searches: 3. advanced searching, MeSH and My NCBI. J Telemed Telecare. 2014 Mar;20(2):102-12. doi: 10.1177/1357633X13519036. PubMed 24614997 ↗
  • Jadad AR, McQuay HJ. Searching the literature. Be systematic in your searching. BMJ. 1993 Jul 3;307(6895):66. doi: 10.1136/bmj.307.6895.66-a. No abstract available. PubMed 8343701 ↗
  • Chang AA, Heskett KM, Davidson TM. Searching the literature using medical subject headings versus text word with PubMed. Laryngoscope. 2006 Feb;116(2):336-40. doi: 10.1097/01.mlg.0000195371.72887.a2. PubMed 16467730 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2017 (actual). Primary completion is estimated for Sep 2017, 8 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 23, 2017
First posted
Sep 5, 2017
StartActual
Jan 12, 2017
Primary completionEst.
Sep 12, 2017
CompletionEst.
Sep 12, 2017
Last update
Sep 6, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 6, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03272282
Lead sponsor
Assiut University
Responsible party
ayman darder (principal investigator, Assiut University) — Principal investigator
First posted
Sep 5, 2017
Start date
Jan 12, 2017
Primary completion
Sep 12, 2017 (estimated)
Completion
Sep 12, 2017 (estimated)
Last update
Sep 6, 2017

Study contacts

abobaker khalil
Contact
kotbnetw@hotmail.com
00201003568474
said mostafa
Contact
saidmostafy9@gmail.com
00201007599819
mohamed khalaph
study director · assiut universty faculity of medicine
ahmad abass
study chair · assiut university faclity of meficibe

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Obstetric Labor Complications →

Other studies from this sponsor

Assiut University →

Start the discussion